2019 Market Size
US$ 3,029.72 Mn
Base year value
2027 Forecast
US$ 6,612.00 Mn
Projected by 2027
CAGR 2020-2027
10.6 %
Growth rate
Addressable Market
US$ 39,165.12 Mn
(2020-2027)
The Neuromodulation market in North America is expected to grow from US$ 3,029.72 million in 2019 to US$ 6,612.00 Million by 2027. This represents a CAGR of 10.6% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to increasing incidence of neurological disorders, growing developments in neuromodulation technology are projected to drive the North America neuromodulation market during the forecast period.
The US has observed fast growth in the neuromodulation market within the past few years and is expected to lead the market in North America during the forecast period. Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA NEUROMODULATION – MARKET SEGMENTATION
By Technology
- External (Non-Invasive) Neuromodulation
- Respiratory Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Internal Neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
By Application
- Chronic Pain Management
- Failed Back Syndrome
- Epilepsy
- Tremor
- Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson’s Disease
- Obsessive-Compulsive Disorder
- Migraine
By End User
- Hospitals
- Clinics
- Home Healthcare
By Country
- US
- Canada
- Mexico
Company Profiles
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
North American Neuromodulation Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 3,029.72 Million |
| Market Size by 2027 | US$ 6,612.00 Million |
| CAGR (2020 - 2027) | 10.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
